[go: up one dir, main page]

TR201917367A2 - A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT - Google Patents

A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT

Info

Publication number
TR201917367A2
TR201917367A2 TR2019/17367A TR201917367A TR201917367A2 TR 201917367 A2 TR201917367 A2 TR 201917367A2 TR 2019/17367 A TR2019/17367 A TR 2019/17367A TR 201917367 A TR201917367 A TR 201917367A TR 201917367 A2 TR201917367 A2 TR 201917367A2
Authority
TR
Turkey
Prior art keywords
hair loss
product suitable
manufacturing
amniotic
scar treatment
Prior art date
Application number
TR2019/17367A
Other languages
Turkish (tr)
Other versions
TR201917367A1 (en
Inventor
Tümentemur Gamze
Yurtsever Bulut
Gani̇me Aygün Eli̇f
Ovali Ercüment
Original Assignee
Ercuement Ovali
Acibadem Mehmet Ali Aydinlar Ueniversitesi
Acibadem Labmed Saglik Hizmetleri A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ercuement Ovali, Acibadem Mehmet Ali Aydinlar Ueniversitesi, Acibadem Labmed Saglik Hizmetleri A S filed Critical Ercuement Ovali
Priority to TR2019/17367A priority Critical patent/TR201917367A2/en
Priority to PCT/TR2020/050709 priority patent/WO2021091502A1/en
Publication of TR201917367A1 publication Critical patent/TR201917367A1/en
Publication of TR201917367A2 publication Critical patent/TR201917367A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Bu buluş; en az üç farklı kaynaktan amniyotik sıvının toplanması (i), farklı kaynaklardan alınan amniyotik sıvıların beraberce havuzlanması (ii), havuzlanarak standardize edilen amniyotik sıvının filtrasyonu (iii), filtre edilen amniyotik sıvının liyofilizasyonu (iv), liyofilize edilen amniyotik malzemenin ışınlanması (v) adımlarını içeren; deri üzerine lokal olarak veya deri altına enjekte edilmek suretiyle saç dökülmesi ve skar tedavisinde kullanıma uygun bir ürünün üretimi için bir yöntem ile ilgilidir.This invention; collection of amniotic fluid from at least three different sources (i), pooling of amniotic fluids from different sources together (ii), filtration of amniotic fluid standardized by pooling (iii), lyophilization of filtered amniotic fluid (iv), irradiation of lyophilized amniotic material (v) including the steps; It relates to a method for the manufacture of a product suitable for use in the treatment of hair loss and scarring, by local or subcutaneous injection on the skin.

TR2019/17367A 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT TR201917367A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17367A TR201917367A2 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT
PCT/TR2020/050709 WO2021091502A1 (en) 2019-11-08 2020-08-14 A method for producing a product suitable for use in the treatment of hair loss and scar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17367A TR201917367A2 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT

Publications (2)

Publication Number Publication Date
TR201917367A1 TR201917367A1 (en) 2021-05-21
TR201917367A2 true TR201917367A2 (en) 2021-05-21

Family

ID=75848949

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17367A TR201917367A2 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT

Country Status (2)

Country Link
TR (1) TR201917367A2 (en)
WO (1) WO2021091502A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119421718A (en) * 2022-04-25 2025-02-11 生物组织控股公司 Compositions and methods involving mixed fetal support tissue
EP4387601A4 (en) * 2022-06-15 2025-02-12 Ovali, Ercüment A method for the production of a product used for immune modulation and regeneration purposes in alopecia areata, androgenetic alopecia, scar, neurodegenerative inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
MA45272A (en) * 2015-06-27 2018-05-02 Stimlabs Llc AMNIOTIC FLUID PRODUCTS AND METHODS OF USE
US20170100440A1 (en) * 2015-10-09 2017-04-13 MAM Holdings of West Florida, L.L.C. Amniotic fluid topical formulation
EP3432896A4 (en) * 2016-03-23 2020-01-15 MiMedx Group, Inc. Compositions and methods of treatment with amniotic fluid

Also Published As

Publication number Publication date
TR201917367A1 (en) 2021-05-21
WO2021091502A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
TR201917367A2 (en) A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT
MX2021003765A (en) IL-12 FUSION PROTEINS TO HETERODIMER FC.
CY1124023T1 (en) HUMAN ANTI-FEL D1 ANTIBODIES AND METHODS OF USING THEREOF
CL2019002953A1 (en) Anti-pd-l1 antibody and its use.
BR112017014269A2 (en) natural killer cells and their uses
AT348778B (en) NEEDLEED FLEECE, ESPECIALLY FOR USE AS ARTIFICIAL LEATHER, AND METHOD FOR PRODUCING THE SAME
MY196756A (en) Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
TR201906285T4 (en) Removal of tumor cells from intraoperative autologous blood rescue.
MX2012011636A (en) Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation.
MX2021006398A (en) EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS.
EP4257614A3 (en) Pharmaceutical combinations comprising an anti-ly75 antibody
MX2021003825A (en) Methods of treating subcutaneous fat layers.
MX2022004873A (en) TGF-? POLYPEPTIDES.
Kontos et al. Pressure dressing in breast surgery: is this the solution for seroma formation?
TR201907630T4 (en) System and method for forming waffle blocks.
EP4413196A4 (en) FABRICS, SURFACE COVERS THEREOF AND SYSTEMS AND METHODS FOR THE MANUFACTURE THEREOF
MX2018015474A (en) METHODS FOR THE DIAGNOSIS AND TREATMENT OF METASTATIC CANCER.
RU2013122556A (en) METHOD FOR REJUVENATING FACE AND NECK SKIN
WO2019199842A3 (en) Blood reader systems and theranostics for brain damage and injury
CN110325551A (en) A kind of Chimeric antigen receptor and its application
CR20200318A (en) METHOD FOR IDENTIFYING AND ISOLATING BIOACTIVE COMPOUNDS FROM ALGAE EXTRACTS
EP4424702A4 (en) NAD+ protein probe for complete genetic coding based on resonance energy transfer, as well as manufacturing methods and uses thereof.
EP4372088A4 (en) ANTI-EGFRVIII ANTIBODY, POLYPEPTIDE, CELL AND METHOD FOR PRODUCTION
AR105553A1 (en) ANTIBODY OF THE FACTOR 1 RECEPTOR OF SIMILAR TO INSULIN GROWTH (IGF-1R) AND ITS USE TO DIAGNOSE TO CANCER
EP4090799A4 (en) SYSTEMS, METHODS AND MACHINES FOR THE PRODUCTION OF SOLAR FOUNDATIONS